Editorial

News

NEJM responds to claims of bias from Justice Department

The New England Journal of Medicine (NEJM) has hit back at assertions of bias in its editorial policies from Republican activist Edward Martin Jr.

News

four smiling fingers that are very happy to be friends, family concept

pharmaphorum welcomes George Underwood to its editorial helm

With its focus always on top quality, engaging editorial content, pharmaphorum is pleased to announce that George Underwood has taken up the position of Features Editor, effective Dec 3rd

News

FDA approves higher Wegovy dose via 4th priority voucher

The US FDA has approved a fourth product via its new National Priority Voucher Programme -- a 7.2 mg dose of Novo Nordisk's weight loss drug Wegovy (semaglutide), to be marketed as Wegovy HD.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Editor's Picks